AKTX
Akari Therapeutics Plc
+0.13 (+1.28%)10.25USD27.4K成交股數–市值–本益比(近四季)–股價營收比–營收年增(近四季)–下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。外國發行人(20-F)通常只申報半年或年度,逐季會有缺。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | – | – | – | – | – | – | – | 0.00 | – | – | – | 0.00 |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 2.1M | 1.5M | 1.1M | 249K | 667K | 813K | 143K | 3.3M | 2.3M | 3.7M | −314K | 371K |
| 銷售管理費用 | 2.5M | 2.2M | 2.1M | 2.0M | 2.5M | 2.7M | 1.7M | 2.2M | 3.7M | 2.6M | 2.8M | 3.1M |
| 營業利益 | −4.6M+48% | −15.8M+347% | −3.2M+10% | −7.4M-1% | −3.1M-48% | −3.5M-50% | −2.9M+17% | −7.4M+179% | −6.0M | −7.0M | −2.5M | −2.7M |
| 營業利益率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稅後淨利 | −4.8M+154% | −14.5M+290% | −5.3M+83% | −6.4M-15% | −1.9M-66% | −3.7M-10% | −2.9M+1% | −7.6M+89% | −5.6M | −4.1M | −2.9M | −4.0M |
| 淨利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稀釋 EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00-100% | 0.00 | 0.00-100% | 0.00 | 0.29 | 0.00 | -0.29 |
| 稀釋股數 | 143.32B | 118.76B | 67.33B | 65.33B | 62.94B | 54.59B | 24.39B | 18.84B | 13.45B | 9.79B | 10.12B | 20.3M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 7.7M | 2.8M | 5.2M | 2.5M | 2.7M | 2.6M | 2.2M | 236K | 1.3M | 3.8M | 4.7M | 214K |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 38.6M | 33.9M | 47.9M | 45.4M | 50.9M | 51.0M | 2.7M | 1.4M | 2.8M | 4.4M | – | 8.0M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 20.0M | 19.5M | 19.6M | 22.7M | 25.3M | 29.2M | – | 24.0M | – | 4.6M | – | 5.2M |
| 股東權益 | 18.6M | 14.4M | 28.3M | 22.7M | 25.6M | 21.7M | −6.7M | −3.7M | −3.6M | −229K | 213K | 2.8M |
| 負債比 | 51.9% | 57.6% | 40.9% | 50.0% | 49.7% | 57.3% | – | 1,674.6% | – | 105.3% | – | 65.3% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −2.5M+16% | – | – | – | −2.2M | – | – | −4.0M | – | – | – |
| 資本支出 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流 | – | – | – | – | – | – | – | – | – | – | – | – |
| 折舊攤銷 | – | – | – | – | – | – | – | – | 13K | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | – | – | −17.3M | –% | 0.00 | – |
| FY2024 | – | – | −19.8M | –% | 0.00 | – |
| FY2023 | 368K | -39.5% | −10.0M | -2,720.5% | 0.00 | −16.4M |
| FY2022 | 608K | – | −13.1M | -2,153.9% | -0.74 | −7.6M |
| FY2021 | – | – | −17.4M | –% | 0.00 | – |
| FY2020 | – | – | −17.1M | –% | -0.01 | – |
| FY2019 | – | – | −16.8M | –% | -0.01 | −12.9M |
| FY2018 | – | – | −20.5M | –% | -0.01 | −22.8M |